DAFTAR PUSTAKA

Cashman JR structural and catalytic properties of the flavin-containing

monooxygenase. Chem res toxicol 8:165-181, 1995
Foth H : role of the lung in accumulation and metabolism of xenobitotic compounsimplicatoins for chemically induced toxicity. Crit rev toxicol 25: 165-205, 1995
Daniel V : glutathione s-transferases : gene structure and regulation of expression.
Crit rev bionchem mol biol 28: 173-207, 1993
Eling T, Thompson DC, foureman GL, et al : prostaglandin H synthase and xenobiotic
oxidation. Ann rev Pharmacol Toxicol 30: 1-45. 1990
Gillete JR: keynote address: man, mice, microcomes, metebolites, and mathematics
40 years after the revolution. Drug metabol Rev 27: 1-44, 1995
Goeptar AR, scheerens H, vermeulan NPE : oxygen and xenobiotic reductase
activaties of cytochrome P450. Crit Rev Toxical 25: 25-65, 1995
Gonzalez FJ, gelboin HV : role of human cytochromes p450 in the metabolic
activation of chemical carcinogens and toxins. Drug metabol Rev 26: 165-183, 1994
Guengerich FP; Cytochrome P450 enzymes. American scientist 81: 440-447, 1993
Guengerich FP; metabolic activations of carcinogens. Pharmacy ther 54: 17-61,
1992
Hodgson E, levi PE (eds): introduction to biochemical toxycologi . Norwalk, CT:
Appleton & lange, 1994
Kitada M, kamataki T: cytochrome P450 in human fetal liver, significance and fetalspecific expression. Drug Metabol Rev 26: 305-323, 1992
Krisna DR, klotz U: extrahepatic metabolism of drug in humans. Clin
pharmacokinetic 26: 144-160, 1994
Parkinsom A: biotranformations of xenobiotions. In casarett & doutts toxicology, the
basic science of poison, 56th ed, new York : mcgraw-hill 1996, pp 113-186
Smith CAD, smith G, worl CR : genetic polymorphisms in xenobiotic metabolism, eur
j cancer 30A 1935-1941, 1994
Tephly TR, isolation and purifications of UDP glucuronosytranferases, in frontier in
molecular toxicology, marnet LJ (ed), Washington DC american chemical society,
1992 pp 125-132